Clinical Trial Update: Cymbalta for Fibromyalgia Pain - Predictive Value of Small Fiber Changed [Phase 4]

View source ↗

Summary

A Phase 4 trial investigating Cymbalta (duloxetine) for fibromyalgia pain was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fibromyalgia

Drugs mentioned

• Cymbalta (duloxetine)

Snippet

Sponsor: University of California, San Diego | Conditions: Fibromyalgia | Phase 4 | Status: WITHDRAWN